Chockalingam ‘Palani’ Palaniappan, Ph.D

Chief Innovation Officer

Chockalingam ‘Palani’ Palaniappan, Ph.D

Chockalingam “Palani” Palaniappan, chief innovation officer, is responsible for driving a culture of innovation for Ortho’s global business, with a strong focus on enhancing product development productivity and processes and implementing creative commercial business models.

Chockalingam “Palani” Palaniappan, chief innovation officer at Ortho Clinical Diagnostics (Ortho), is responsible for driving a culture of innovation for Ortho’s global business, with a strong focus on enhancing product development productivity and processes and implementing creative commercial business models.

Palaniappan is a seasoned innovation leader in the life science industry with a proven track record of championing transformative innovation and development for commercial impact.

Prior to joining Ortho, Palaniappan served as chief technology officer at Epic Sciences, a privately held young growth company headquartered in San Diego that focuses on personalized medicine. He previously served as executive vice president and senior vice president for global innovation and development at Terumo BCT, a medical device subsidiary of Terumo Corporation headquartered in Lakewood, Colo., that focuses on tools for automation in blood transfusion and regenerative medicine. Earlier, he was vice president for research and development in the cellular analysis division of Life Technologies Corp., a life sciences company in Eugene, Ore., providing labeling and detection services for DNA, RNA, protein and cells that subsequently was acquired by Thermo Fisher Scientific. He also served as head of molecular diagnostics research and development at Amersham Biosciences, a unit of GE Healthcare in Piscataway, N.J.

Palaniappan has served as a board member for Terumo Global Business Management and the State of Oregon Biosciences and Technology Initiatives, OTRADI & ONAMI. He also received the City of Lakewood Mayor’s Inspirational Leadership in Healthcare recognition in 2017.

Palaniappan holds a Ph.D. in biological sciences from Northern Illinois University and was a post-doctoral research fellow with the department of biochemistry and biophysics at the University of Rochester.